Vaccines by Oxford University-Serum Institute of India, Moderna, approved to advance to phase 2 trials, with more than 140 participants enrolled in broader trial
Vaccines by Oxford University-Serum Institute of India, Moderna, approved to advance to phase 2 trials, with more than 140 participants enrolled in broader trial
Eastern Mediterranean deaths, disappearances surge 80%, while hundreds of Rohingya refugees also perish on Asian maritime routes, says UNHCR17 November 2026
Experts warn climate tech startups face challenges securing investments, urge development banks to assume some losses on unproven tech to help transition to market17 November 2026
Citing recent findings, Kalliopi Mingeirou says 98% of the deepfake material examined is pornographic, with women accounting for 99% of those targeted17 November 2026
IOM, WFP say funding shortages and access restrictions risk worsening shelter and food crises, with nearly 2 million people needing shelter assistance17 November 2026